Articles with public access mandates - Hang XuLearn more
Available somewhere: 19
Tracking the evolution of non–small-cell lung cancer
M Jamal-Hanjani, GA Wilson, N McGranahan, NJ Birkbak, TBK Watkins, ...
New England Journal of Medicine 376 (22), 2109-2121, 2017
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
C Abbosh, NJ Birkbak, GA Wilson, M Jamal-Hanjani, T Constantin, ...
Nature 545 (7655), 446-451, 2017
Mandates: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Allele-specific HLA loss and immune escape in lung cancer evolution
N McGranahan, R Rosenthal, CT Hiley, AJ Rowan, TBK Watkins, ...
Cell 171 (6), 1259-1271. e11, 2017
Mandates: Versus Arthritis, UK, Cancer Research UK, UK Medical Research Council …
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
S Turajlic, K Litchfield, H Xu, R Rosenthal, N McGranahan, JL Reading, ...
The lancet oncology 18 (8), 1009-1021, 2017
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal
S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ...
Cell 173 (3), 581-594. e12, 2018
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Deterministic evolutionary trajectories influence primary tumor growth: TRACERx renal
S Turajlic, H Xu, K Litchfield, A Rowan, S Horswell, T Chambers, ...
Cell 173 (3), 595-610. e11, 2018
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal
TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ...
Cell 173 (3), 611-623. e17, 2018
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Fc-optimized anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors
FA Vargas, AJS Furness, I Solomon, K Joshi, L Mekkaoui, MH Lesko, ...
Immunity 46 (4), 577-586, 2017
Mandates: Blood Cancer UK, Cancer Research UK, UK Engineering and Physical Sciences …
Pervasive chromosomal instability and karyotype order in tumour evolution
TBK Watkins, EL Lim, M Petkovic, S Elizalde, NJ Birkbak, GA Wilson, ...
Nature 587 (7832), 126-132, 2020
Mandates: US Department of Defense, US National Institutes of Health, Helmholtz …
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
L Au, E Hatipoglu, MR de Massy, K Litchfield, G Beattie, A Rowan, ...
Cancer cell 39 (11), 1497-1518. e11, 2021
Mandates: Versus Arthritis, UK, Cancer Research UK, UK Medical Research Council …
A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
YH Lo, KS Kolahi, Y Du, CY Chang, A Krokhotin, A Nair, WD Sobba, ...
Cancer discovery 11 (6), 1562-1581, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Swedish …
Cell of origin influences pancreatic cancer subtype
BM Flowers, H Xu, AS Mulligan, KJ Hanson, JA Seoane, H Vogel, ...
Cancer discovery 11 (3), 660-677, 2021
Mandates: US National Institutes of Health
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
K Litchfield, JL Reading, EL Lim, H Xu, P Liu, M Al-Bakir, YNS Wong, ...
Nature communications 11 (1), 3800, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Representative sequencing: unbiased sampling of solid tumor tissue
K Litchfield, S Stanislaw, L Spain, LL Gallegos, A Rowan, D Schnidrig, ...
Cell reports 31 (5), 2020
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Selection of metastasis competent subclones in the tumour interior
Y Zhao, X Fu, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ...
Nature ecology & evolution 5 (7), 1033-1045, 2021
Mandates: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study
X Fu, Y Zhao, JI Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ...
Nature ecology & evolution 6 (1), 88-102, 2022
Mandates: US National Institutes of Health, Versus Arthritis, UK, Cancer Research UK …
Late-stage metastatic melanoma emerges through a diversity of evolutionary pathways
L Spain, A Coulton, I Lobon, A Rowan, D Schnidrig, STC Shepherd, ...
Cancer discovery 13 (6), 1364-1385, 2023
Mandates: US Department of Defense, US National Institutes of Health, Versus Arthritis …
Automated design of paralogue ratio test assays for the accurate and rapid typing of copy number variation
CD Veal, H Xu, K Reekie, R Free, RJ Hardwick, D McVey, AJ Brookes, ...
Bioinformatics 29 (16), 1997-2003, 2013
Mandates: UK Medical Research Council
Selection of metastasis competent subclones in the tumour interior: TRACERx renal
Y Zhao, X Fu, J Lopez, A Rowan, L Au, A Fendler, S Hazell, H Xu, ...
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Publication and funding information is determined automatically by a computer program